Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Respiratory Remote Patient Monitor (Spire Health Tag)

"The RPM service, tailored to chronic respiratory disease patients, utilizes a system that includes three components: undergarment-adhered cardiorespiratory sensors, in-home data transmission hub, and web-based clinical dashboard. The sensors are a set of six proprietary, skin-safe devices that include sensors for intermittent photoplethysmography, continuous respiratory force, and tri-axis accelerometers for activity. Clinical liaisons monitor deviations from patient-specific baselines and contact subjects for a risk assessment call, including questions about symptoms. If a subject fails the risk assessment, they are escalated to the site to be seen, and potentially treated, by their pulmonologist."

Trial Locations (1)

94110

Spire, Inc., San Francisco

All Listed Sponsors
collaborator

Pulmonary Associates of Richmond

UNKNOWN

collaborator

The University of Texas Health Science Center at San Antonio

OTHER

lead

Spire, Inc.

INDUSTRY

NCT05518981 - Effect of Remote Physiologic Monitoring (RPM) on Outcomes in COPD Patients | Biotech Hunter | Biotech Hunter